- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01629901
Caloric Stimulation on Cerebral Blood Flow
March 20, 2017 updated by: Duke University
The Effect of Vestibular Stimulation on Cerebral Blood Flow
This is a prospective, non-randomized study designed to generate preliminary data to assess the effect of a new portable non-invasive caloric stimulator on EEG waveform and cerebral blood flow on normal healthy volunteers.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Study activities include monitoring with bilateral transcranial Doppler (TCD), EEG and continuous EKG monitoring at 30 second intervals for 5 minutes.
This is followed by placement of the caloric stimulator investigational device for 20 minutes.
An additional 20 minutes of TCD and EEG monitoring will also be recorded.
This will end study participation.
Study Type
Interventional
Enrollment (Actual)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27710
- Duke University Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- no history of neurological disease
Exclusion Criteria:
- persons under the age of 18
- pregnant or nursing women
- history of neurological disease
- history of psychiatric disease
- congenital heart defect, known cardiac shunt
- inner ear or pulmonary disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in cerebral blood flow
Time Frame: 20 minutes
|
Changes in cerebral blood flow will be quantified through the use of bilateral transcranial Doppler (TCD).
The baseline TCD of three vessels will be compared with measurements taken at 30 second intervals for 5 minutes after caloric stimulation.
|
20 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Alterations in EEG readings
Time Frame: 40 minutes
|
EEG readings occurring between baseline, active CVS induction, and post-CVS induction periods will be assessed to identify and characterize alterations in the readings.
|
40 minutes
|
|
Alterations in regional cerebral brain flow (rCBF)
Time Frame: 40 minutes
|
A standard noninvasive near infrared spectroscopy system will be used to look for any alterations in rCBF induced by CVS treatment.
|
40 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Daniel Laskowitz, MD, Duke University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2012
Primary Completion (Actual)
March 1, 2015
Study Completion (Actual)
April 1, 2015
Study Registration Dates
First Submitted
June 26, 2012
First Submitted That Met QC Criteria
June 26, 2012
First Posted (Estimate)
June 28, 2012
Study Record Updates
Last Update Posted (Actual)
March 21, 2017
Last Update Submitted That Met QC Criteria
March 20, 2017
Last Verified
June 1, 2015
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- Pro00035775
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Volunteer
-
University Magna GraeciaNot yet recruitingHealthy Volunteer | Healthy Volunteer StudyItaly
-
National Heart, Lung, and Blood Institute (NHLBI)TerminatedHealthy | Healthy Volunteer | HVUnited States
-
Hospices Civils de LyonNot yet recruiting
-
AbbVieNot yet recruiting
-
TrueLab Biopharmaceutical Co., LtdSAPRO Consulting Pty LtdRecruiting
-
Aspargo Labs, IncNot yet recruitingHealthy Volunteer
-
Aspargo Labs, IncNot yet recruiting
-
Aspargo Labs, IncNot yet recruiting
-
AbbVieRecruitingHealthy VolunteerUnited States
-
Johns Hopkins UniversityRecruitingHealthy VolunteerUnited States
Clinical Trials on ThermoNeuroModulation (TNM) Device
-
Wake Forest University Health SciencesWithdrawnSubstance Use DisordersUnited States
-
VA Office of Research and DevelopmentUS Department of Veterans AffairsCompleted
-
Scion NeuroStimCompletedParkinson Disease | Parkinson's Disease and ParkinsonismUnited States, United Kingdom
-
Scion NeuroStimDuke UniversityCompletedPost-stroke AphasiaUnited States
-
Scion NeuroStimTerminatedType 2 DiabetesUnited States
-
Scion NeuroStimTerminatedParkinson's DiseaseUnited States
-
Scion NeuroStimCompleted
-
University of MichiganNational Institute of Neurological Disorders and Stroke (NINDS)Not yet recruiting
-
MedtronicNeuroCompletedOveractive BladderUnited States
-
MedtronicNeuroCompletedOveractive BladderUnited States